Study for renal outcomes with different combination therapies including Telmisartan in patients with type 2 diabetes and hypertensio
Phase 4
- Conditions
- type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000005865
- Lead Sponsor
- Hokkaido University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 105
Inclusion Criteria
Not provided
Exclusion Criteria
1) severe hepatic dysfunction, renal dysfunction, heart failure, 2) history of anaphylaxis of Telmisartan, Hydrochlorothiazide or Amlodipine , 3) pregnancy, 4) patients who are inadequate to enter this study due to the other reasons by physician's judgments
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method